ARO-HIF2
AROHIF21001
Phase 1 small_molecule completed
Quick answer
ARO-HIF2 for Clear Cell Renal Cell Carcinoma is a Phase 1 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Clear Cell Renal Cell Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed